Endocrine Effects of Checkpoint Inhibitor Therapy

8:15 AM - 9:00 AM
Location: Convention Center Hall B

Kevan Herold, MD

Professor of Immunobiology and Internal Medicine
Yale University

Dr. Kevan Herold, M.D., Ph.D. is a Professor of Immunobiology and Medicine at Yale University. Dr. Herold work in the field of Type 1 diabetes is well known, including his pioneering work with Dr. Jeff Bluestone that showed the efficacy of anti-CD3 mAb treatment of Type 1 diabetes. His work is translational, bridging the fields of basic immunology, clinical trials, and clinical medicine, which will enable this Program to rapidly move advances in preclinical studies to clinical testing. He has long standing collaborations with Dr. Bluestone and with Dr. Mattias von Herrath. Dr. Herold is the Principal Investigator on 3 clinical trials supported by the Immune Tolerance Network, and TrialNet. Dr. Herold is an Endocrinologist with a special interest in autoimmune diseases and diabetes and sees both adolescent and adult patients with all forms of diabetes and other metabolic disorders. Dr. Herold is a Member of Scientific Advisory Board at Cour Pharmaceutical Development Company, Inc. Dr. Herold has been a Member of Scientific Advisory Board at Islet Sciences, Inc. since September 6, 2012. He is a Member of Scientific Advisory Board at Tiziana Life Sciences PLC since November 1, 2016. He is a Member of Type 1 Diabetes Scientific Advisory Board at Caladrius Biosciences, Inc. Dr. Herold is conducting research on immunotherapy for treatment of Type 1 diabetes. Dr. Herold's laboratory work involves studies of induction of immunologic tolerance to autoimmunity.


Send Email for Kevan Herold

Sandra L. Weber, MD, FACE


Dr. Weber has been a member of AACE since 1994. She served as President of the Carolinas Chapter-AACE from 2006 to 2008. She has served on several AACE Committees, including Chair of the 24th Annual AACE Scientific & Clinical Congress Program Committee, ACE Funding Development Committee, Chapters Committee, Legislative and Regulatory Committee, Bylaws Committee, and more. She is currently President Elect of the great organization.
Dr. Weber currently practices endocrinology in Greenville, South Carolina, where she is one of the founding faculty at the University of South Carolina School of Medicine in Greenville. Also, she is involved in the residency teaching program, is active in clinical research, and serves as Chief of the Division of Endocrinology and Chair of Continuing Medical Education at Greenville Health System, University Medical Group.


Send Email for Sandra Weber


SP1 - Diabetes and other Endocrine Adverse Events from Checkpoint Inhibitor Therapy

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Diabetes and other Endocrine Adverse Events from Checkpoint Inhibitor Therapy